Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?
brachytherapy
cervical cancer
conization
early stage
minimally invasive surgery
radical hysterectomy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
09
02
2023
revised:
23
02
2023
accepted:
27
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
(1) This study aims to evaluate the overall survival (OS) and recurrence-free survivals (RFS) and assess disease recurrence of early-stage cervical cancer (ESCC) patients treated with minimally invasive surgery (MIS). (2) This single-center retrospective analysis was performed between January 1999 and December 2018, including all patients managed with MIS for ESCC. (3) All 239 patients included in the study underwent pelvic lymphadenectomy followed by radical hysterectomy without the use of an intrauterine manipulator. Preoperative brachytherapy was performed in 125 patients with tumors measuring 2 to 4 cm. The 5-year OS and RFS rates were 92% and 86.9%, respectively. Multivariate analysis found two significant factors associated with recurrence: previous conization with HR = 0.21,
Identifiants
pubmed: 36900360
pii: cancers15051570
doi: 10.3390/cancers15051570
pmc: PMC10001182
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Bull Cancer. 2019 Oct;106(10):939-940
pubmed: 31353135
Brachytherapy. 2013 Mar-Apr;12(2):148-55
pubmed: 22727471
Int J Gynecol Cancer. 2018 Jun;28(5):1020-1028
pubmed: 29727351
Obstet Gynecol. 2019 Jun;133(6):1086-1098
pubmed: 31135722
Lancet. 1997 Aug 23;350(9077):535-40
pubmed: 9284774
Surg Oncol. 2009 Dec;18(4):289-97
pubmed: 18805001
Int J Gynecol Cancer. 2022 Feb;32(2):117-124
pubmed: 35039455
Am J Obstet Gynecol. 2020 Mar;222(3):249.e1-249.e10
pubmed: 31586602
Gynecol Obstet Fertil. 2015 Jul-Aug;43(7-8):485-90
pubmed: 25986397
Ann Surg Oncol. 2013 Mar;20(3):872-80
pubmed: 22932859
Ann Surg Oncol. 2017 Oct;24(11):3406-3412
pubmed: 28785898
Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93
pubmed: 12377330
Arch Gynecol Obstet. 2021 Aug;304(2):503-510
pubmed: 33483846
Gynecol Oncol. 2017 Mar;144(3):541-546
pubmed: 28095994
BJOG. 2019 Jul;126(8):956-959
pubmed: 30658010
J Minim Invasive Gynecol. 2021 Jan;28(1):117-123
pubmed: 32320800
JAMA Oncol. 2020 Jul 1;6(7):1019-1027
pubmed: 32525511
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Gynecol Oncol. 2020 Oct;159(1):164-170
pubmed: 32665147
N Engl J Med. 2018 Nov 15;379(20):1905-1914
pubmed: 30379613
Int J Gynecol Cancer. 2019 Jun;29(5):845-850
pubmed: 31155516
Int J Gynecol Cancer. 2015 May;25(4):714-21
pubmed: 25647258
J Laparoendosc Adv Surg Tech A. 2017 Nov;27(11):1132-1144
pubmed: 28300465
Int J Gynecol Cancer. 2020 Sep;30(9):1269-1277
pubmed: 32788262
Med Sci Monit. 2014 Dec 01;20:2497-503
pubmed: 25436974
Eur J Surg Oncol. 2012 Mar;38(3):203-9
pubmed: 22244909
Eur J Cancer. 2019 Jul;116:169-177
pubmed: 31200323
Ann Surg Oncol. 2021 Jul;28(7):3585-3594
pubmed: 33620615
Radiother Oncol. 2018 Jun;127(3):404-416
pubmed: 29728273
Gynecol Oncol. 2022 Aug;166(2):230-235
pubmed: 35644731
Chin Med J (Engl). 2016 Jun 5;129(11):1305-10
pubmed: 27231167
Int J Gynecol Cancer. 2020 Feb;30(2):181-186
pubmed: 31871113
Gynecol Oncol. 2021 Apr;161(1):166-172
pubmed: 33563488
Gynecol Obstet Fertil. 2007 Mar;35(3):263-4
pubmed: 17317265
J Obstet Gynaecol Res. 2019 Dec;45(12):2425-2434
pubmed: 31502349
Brachytherapy. 2022 May-Jun;21(3):273-282
pubmed: 35094933
Int J Gynaecol Obstet. 2019 Apr;145(1):129-135
pubmed: 30656645
Am J Obstet Gynecol. 2019 Dec;221(6):619.e1-619.e24
pubmed: 31288006
Lancet Oncol. 2008 Mar;9(3):297-303
pubmed: 18308255
Cancer. 1999 Sep 1;86(5):770-4
pubmed: 10463974
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365